Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 23 September 1983:
Vol. 221. no. 4617, pp. 1285 - 1288
DOI: 10.1126/science.6137059

Articles

Science, Vol 221, Issue 4617, 1285-1288
Copyright © 1983 by American Association for the Advancement of Science


articles

Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines

N Kartner, Riordan JR, and V Ling

The plasma membranes of hamster, mouse, and human tumor cell lines that display multiple resistance to drugs were examined by gel electrophoresis and immunoblotting. In every case, increased expression of a 170,000-dalton surface antigen was found to be correlated with multidrug resistance. This membrane component is of identical molecular size and shares some immunogenic homology with the previously characterized P-glycoprotein of colchicine-resistant Chinese hamster ovary cells. This finding may have application to cancer therapy.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Concise Review: Clinical Relevance of Drug Drug and Herb Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein).
S. Marchetti, R. Mazzanti, J. H. Beijnen, and J. H. M. Schellens (2007)
Oncologist 12, 927-941
   Abstract »    Full Text »    PDF »
Molecular Pharmacokinetics of Catharanthus (Vinca) Alkaloids.
D. Leveque and F. Jehl (2007)
J. Clin. Pharmacol. 47, 579-588
   Abstract »    Full Text »    PDF »
P-Glycoprotein-Independent Apoptosis Induction by a Novel Synthetic Compound, MMPT [5-[(4-Methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].
F. Teraishi, S. Wu, J. Sasaki, L. Zhang, H.-B. Zhu, J. J. Davis, and B. Fang (2005)
J. Pharmacol. Exp. Ther. 314, 355-362
   Abstract »    Full Text »    PDF »
Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating Agents.
G. Francia, S. Man, B. Teicher, L. Grasso, and R. S. Kerbel (2004)
Mol. Cell. Biol. 24, 6837-6849
   Abstract »    Full Text »    PDF »
Intestinal P Glycoprotein Acts as a Natural Defense Mechanism against Listeria monocytogenes.
B. L. Neudeck, J. M. Loeb, N. G. Faith, and C. J. Czuprynski (2004)
Infect. Immun. 72, 3849-3854
   Abstract »    Full Text »    PDF »
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.
T.-L. Wang, L. A. Diaz Jr., K. Romans, A. Bardelli, S. Saha, G. Galizia, M. Choti, R. Donehower, G. Parmigiani, I.-M. Shih, et al. (2004)
PNAS 101, 3089-3094
   Abstract »    Full Text »    PDF »
Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro.
S. K. Green, G. Francia, C. Isidoro, and R. S. Kerbel (2004)
Mol. Cancer Ther. 3, 149-159
   Abstract »    Full Text »    PDF »
Multidrug-resistant Cancer Cells Facilitate E1-independent Adenoviral Replication: Impact for Cancer Gene Therapy.
P. S. Holm, H. Lage, S. Bergmann, K. Jurchott, G. Glockzin, A. Bernshausen, K. Mantwill, A. Ladhoff, A. Wichert, J. S. Mymryk, et al. (2004)
Cancer Res. 64, 322-328
   Abstract »    Full Text »    PDF »
Subcellular Localization and Activity of Multidrug Resistance Proteins.
A. Rajagopal and S. M. Simon (2003)
Mol. Biol. Cell 14, 3389-3399
   Abstract »    Full Text »    PDF »
Increased Penetration of Paclitaxel into the Brain by Inhibition of P-Glycoprotein.
E. M. Kemper, A. E. van Zandbergen, C. Cleypool, H. A. Mos, W. Boogerd, J. H. Beijnen, and O. van Tellingen (2003)
Clin. Cancer Res. 9, 2849-2855
   Abstract »    Full Text »    PDF »
Apoptotic Susceptibility of Cancer Cells Selected for Camptothecin Resistance: Gene Expression Profiling, Functional Analysis, and Molecular Interaction Mapping.
W. C. Reinhold, H. Kouros-Mehr, K. W. Kohn, A. K. Maunakea, S. Lababidi, A. Roschke, K. Stover, J. Alexander, P. Pantazis, L. Miller, et al. (2003)
Cancer Res. 63, 1000-1011
   Abstract »    Full Text »    PDF »
Effects of the Flavonoids Biochanin A, Morin, Phloretin, and Silymarin on P-Glycoprotein-Mediated Transport.
S. Zhang and M. E. Morris (2003)
J. Pharmacol. Exp. Ther. 304, 1258-1267
   Abstract »    Full Text »    PDF »
Association of the P-Glycoprotein Transporter MDR1C3435T Polymorphism with the Susceptibility to Renal Epithelial Tumors.
M. Siegsmund, U. Brinkmann, E. Schaffeler, G. Weirich, M. Schwab, M. Eichelbaum, P. Fritz, O. Burk, J. Decker, P. Alken, et al. (2002)
J. Am. Soc. Nephrol. 13, 1847-1854
   Abstract »    Full Text »    PDF »
Autocrine Production of Interleukin 6 Causes Multidrug Resistance in Breast Cancer Cells.
D. Conze, L. Weiss, P. S. Regen, A. Bhushan, D. Weaver, P. Johnson, and M. Rincon (2001)
Cancer Res. 61, 8851-8858
   Abstract »    Full Text »    PDF »
MDR1 Gene Overexpression and Altered Degree of Methylation at the Promoter Region in Bladder Cancer during Chemotherapeutic Treatment.
Y. Tada, M. Wada, K. Kuroiwa, N. Kinugawa, T. Harada, J. Nagayama, M. Nakagawa, S. Naito, and M. Kuwano (2000)
Clin. Cancer Res. 6, 4618-4627
   Abstract »    Full Text »
Communication between Multiple Drug Binding Sites on P-glycoprotein.
C. Martin, G. Berridge, C. F. Higgins, P. Mistry, P. Charlton, and R. Callaghan (2000)
Mol. Pharmacol. 58, 624-632
   Abstract »    Full Text »
Energy Metabolism of Human LoVo Colon Carcinoma Cells: Correlation to Drug Resistance and Influence of Lonidamine.
M. Fanciulli, T. Bruno, A. Giovannelli, F. P. Gentile, M. Di Padova, O. Rubiu, and A. Floridi (2000)
Clin. Cancer Res. 6, 1590-1597
   Abstract »    Full Text »
In Situ Biochemical Demonstration that P-Glycoprotein Is a Drug Efflux Pump with Broad Specificity.
Y. Chen and S. M. Simon (2000)
J. Cell Biol. 148, 863-870
   Abstract »    Full Text »    PDF »
Genetic and Epigenetic Factors in Anticancer Drug Resistance.
R. H. Shoemaker (2000)
J Natl Cancer Inst 92, 4-5
   Full Text »    PDF »
Use of a Peptide Mimotope to Guide the Humanization of MRK-16, an Anti-P-glycoprotein Monoclonal Antibody.
Y. Tang, G. Beuerlein, G. Pecht, T. Chilton, W. D. Huse, and J. D. Watkins (1999)
J. Biol. Chem. 274, 27371-27378
   Abstract »    Full Text »    PDF »
Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death.
C. Dumontet and B. I. Sikic (1999)
J. Clin. Oncol. 17, 1061
   Abstract »    Full Text »    PDF »
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias.
M. Nakayama, M. Wada, T. Harada, J. Nagayama, H. Kusaba, K. Ohshima, M. Kozuru, H. Komatsu, R. Ueda, and M. Kuwano (1998)
Blood 92, 4296-4307
   Abstract »    Full Text »    PDF »
QacR Is a Repressor Protein That Regulates Expression of the Staphylococcus aureus Multidrug Efflux Pump QacA.
S. Grkovic, M. H. Brown, N. J. Roberts, I. T. Paulsen, and R. A. Skurray (1998)
J. Biol. Chem. 273, 18665-18673
   Abstract »    Full Text »    PDF »
Resistance to Diverse Drugs and Ultraviolet Light Conferred by Overexpression of a Novel Human 26 S Proteasome Subunit.
V. Spataro, T. Toda, R. Craig, M. Seeger, W. Dubiel, A. L. Harris, and C. Norbury (1997)
J. Biol. Chem. 272, 30470-30475
   Abstract »    Full Text »    PDF »
A Single Chain Fv Fragment of P-glycoprotein-specific Monoclonal Antibody C219. DESIGN, EXPRESSION, AND CRYSTAL STRUCTURE AT 2.4 A RESOLUTION.
F. J. Hoedemaeker, T. Signorelli, K. Johns, D. A. Kuntz, and D. R. Rose (1997)
J. Biol. Chem. 272, 29784-29789
   Abstract »    Full Text »    PDF »
What does Multidrug Resistance (MDR) Expression Mean in the Clinic?.
C. Duhem, F. Ries, and M. Dicato (1996)
Oncologist 1, 151-158
   Abstract »    Full Text »    PDF »
Experimental Models for the Study of Drug Resistance in Osteosarcoma: P-Glycoprotein-Positive, Murine Osteosarcoma Cell Lines.
H. TAKESHITA, M. C. GEBHARDT, D. S. SPRINGFIELD, K. KUSUZAKI, and H. J. MANKIN (1996)
J. Bone Joint Surg. Am. 78, 366-75
   Abstract »    Full Text »
Role of the glutathione redox cycle in acquired and de novo multidrug resistance.
R. Kramer, J Zakher, and G Kim (1988)
Science 241, 694-697
   Abstract »    PDF »
Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.
D. Shen, A Fojo, J. Chin, I. Roninson, N Richert, I Pastan, and M. Gottesman (1986)
Science 232, 643-645
   Abstract »    PDF »
Transport Activity and Surface Expression of the Na+-Ca2+ Exchanger NCX1 Are Inhibited by the Immunosuppressive Agent Cyclosporin A and by the Nonimmunosuppressive Agent PSC833.
C. Kimchi-Sarfaty, J. Kasir, S. V. Ambudkar, and H. Rahamimoff (2002)
J. Biol. Chem. 277, 2505-2510
   Abstract »    Full Text »    PDF »
Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy.
P. Duesberg, R. Stindl, and R. Hehlmann (2001)
PNAS 98, 11283-11288
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)